4 host defense Flashcards

1
Q

what is the parts of the innate immune system?

A

Innate Immunity

Recognition of patterns by PRRs Type I IFN secretion
Secretion of other soluble mediators: Cytokines – IL-1, TNFα,

IFNγ, chemokines, etc… Complement

NK cells
– direct killing of virus-infected cells by NK cells

– and, NK cells are a huge source of IFNγ pro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is responsible fo the early antiviral host defense?

A

the innate immune response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what cant you used INF gamma to treat a viral infection?

A

it is used in certain leukemias but it is limited by its side effects?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what kind of immune response does INF gamma cause?

A

it causes a Th1 immune response

too much causes flu like sympotoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

IFN-γ acEvates

A

macrophages.

acEvated macrophages, DC produce IL-12, TNF, IL1β

IL-12 does good things for NK cells, T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what cytokine is the actiovator for NK cells?

what secretes this?

A

IL-12 is the activator for cytokines.

it is from dendritic cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what aare the cytokines in the type 1 interferon response?

A

IFN -alpha

IFN - beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what causes the release of the type 1 interferons?

A

the PRR recognize stuff that the cell does not have like dsRNA and it causes a IRF interferon response factor that binds to the ISRE

this makes IFN alpha and beta and causes them to be released.

they go out and bind to nearby cells causing them to go in to an antivirla state.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the reaction when the IFN alpha and beta bind to the receptor on others?

A

it makes the jak stat and this binds to DNA and causes them to make PKR and OAS

protein kinase R

oligoadenylate synthase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is PKr?

what is it activated by?

what does it do? by blocking what?

A

it is protein Kinase R

it binds to dsRNA and phosphorylates eIF-2alpha

eIF-2 alpha

delivers Met tRNA to the 40S ribosome to initiate polypeptide synthesis

PKR stops translation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is OAS?

what is it activated by?

what does it do once activated?

A

Type I IFNs activate PKR and 2’-5’ Oligoadenylate Synthase

OAS, like PKR, binds to and is activated by dsRNA

OAS makes oligo AAAA

oligo AAAA activates RNAse L – an endoribonuclease.

RNAse L degrades mRNA

OAS degrades mRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

IFN-α and IFN-β induce ?

what happens to viral protein sythesis?

what happens to surface MHC I

what happens to NK cells?

A

causes the antiviral state.

decrease of viral protein sythesis

increase surface class 1 MHC

increase NKcells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the proinflammatory cytokines?

what ones can induce fever?

A

major pro-inflammatory cytokine (TNF, IL-1, IL-6)

• Induces death signaling

pyrogen TNF, IL-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what cytokine promotes the NK production of IFN gamma?

A

IL12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how do NK cells decide to kill a cell?

A

NK cells kill targets after assessing the balance between”

  • inhibitory signals from class I molecules”
  • activating signals from NK activating ligands”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In a “first response” to virus infection, cells upregulate Type I IFNs Cells also upregulate NK activating ligands in response to virus infection

A
17
Q

p53 tells the cell to die or to survive?

what does it do?

A

it tells the cells to die

it makes bak pores that let out the cytochrome C

this activates caspase which goes into dna and breaks it up.

18
Q

what does bcl-2 and bcl-XL do?

A

they stop the programmed cell death from happening.

19
Q

Viruses encode proteins to prevent IFN binding!

A
20
Q

viruses can stop the IFN signalling from within.

A

bind to PKR and inactivate it.

stop the activation of the PKR

stop eif2a from binding to PKR and activating it.

21
Q

what PRR does influenza impair?

A

RIG-I

that senses the dsRNA fragments.

22
Q

the viral IL-1β binding protein serves to sequester IL-1β and stop its ___________ activity

A

its pyrogenic activity

23
Q

what are “control” proteins?

A

they are proteins that cells make to stop the complemnt proteins from binding to the cell surface and activating.

24
Q

what do viruses do to get around the complemet proteins?

A

they make homologs of the control proteins that prevent the assembly of the MAC complex.

25
Q

viruses can also stop the presentation of class I antigen presentation and diffrent steps along the wya.

A
26
Q

to evade NK cell killing, viruses can: ?

A

make some decoy MHC-1

reomove the importnet parts fo the MHC-1

stop NK cell receptors from activating on the cell surface.

27
Q

viruses can alos downregulate other adhesion molecules.

A

• adhesion molecules (ICAM-1)

costimulatory molecutes like B7

28
Q

viruses alos encode many inhibitors ofr apoptosis.

A

p53 inhibitors

vbcl-2 that inhibit them

v-caspase inhbitors

29
Q

epitope mutation is a strategy that makes more sense for viruses with _________ genomes?

b/c why?

A

with small genomes b/c they can mutate alot faster.

30
Q

The set-point of the immune/inflammatory response determines__________?

b/c why?

A

too little host defense – virus takes over
too much inflammatory response – severe disease

31
Q

  1. Viruses are telling us a tremendous amount about the circuitry of the inflammatory/immune system, and pointing the way to new modulators of the system that will have applications for the treatment of disease, e.g. chronic inflammation, autoimmunity, and potential drug targets
A
32
Q
A